Trials / Completed
CompletedNCT04552353
Evaluate Bioequivalence of Voriconazole(200mg/Vial) .
A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Voriconazole(200mg/Vial) After Intravenous Infusion of 200mg Voriconazole in Healthy Volunteers Under Fasting Conditions.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Yung Shin Pharm. Ind. Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Voriconazole(200mg/Vial) After Intravenous Infusion of 200mg Voriconazole in Healthy Volunteers Under Fasting Conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vaway | Drug: Voriconazole. Pharmacokinetic study under fasting conditions |
Timeline
- Start date
- 2020-06-13
- Primary completion
- 2020-06-21
- Completion
- 2020-06-21
- First posted
- 2020-09-17
- Last updated
- 2020-09-17
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04552353. Inclusion in this directory is not an endorsement.